In the News

Treatment for high-risk COVID-19 patients, vaccine news, research on health messaging

An industry-funded study found benefit with bamlanivimab plus etesevimab for high-risk ambulatory COVID-19 patients, the FDA noted a possible increased risk for Guillain-Barré syndrome with the Johnson & Johnson (Janssen) vaccine, and two studies looked at COVID-19 messaging for minority populations.

ACP hosts free webinar, “COVID-19 Recovery: Increasing Adult Vaccinations”

Topics covered will include current recommendations, immunizations in patients with high-risk chronic conditions, and strategies for increasing vaccination rates.

MKSAP Quiz: 1-year history of weight gain, easy bruising

A 52-year-old woman is evaluated for a 1-year history of a 6.8-kg (15-lb) weight gain, easy bruising, hypertension, and worsening diabetes control. Lab studies reveal hypercortisolism. What is the most likely cause?

Apixaban associated with lower adverse event rates than warfarin in frail patients with afib

A retrospective observational study used Medicare data to compare outcomes of apixaban, rivaroxaban, and dabigatran with warfarin in patients with atrial fibrillation.

Gender pay gap persists in internal medicine, especially in procedural subspecialties

Only general internal medicine, endocrinology, and geriatrics had more women than men, and only 26% of full professors were women, according to an analysis of U.S. internal medicine faculty in 2018 to 2019.

ACP offers new independent practice resources

The newly launched webpage is dedicated to providing independent practice physicians with resources and tools to help with the business side of medicine.

Put words in our mouth

ACP Internist Weekly wants readers to create captions for our new cartoon and help choose the winner. Pen the winning caption and win a $50 gift certificate good toward any ACP product, program, or service.